In this study, we found that tumor cells blocked the differentiation of myeloid progenitors in CD11b+Gr-1− e-MDSCs, but their capacity to differentiate was restored after a deprivation of tumor-derived factors. This evidence concerns the gene ITGAM and neoplasm.